<DOC>
	<DOCNO>NCT00317161</DOCNO>
	<brief_summary>The purpose study demonstrate consistent result 3 production lot Hib-MenAC vaccine extemporaneously mixed Tritanrix™-HepB administer single injection , respect immunogenicity , safety reactogenicity . Tritanrix™-HepB/Hiberix™ give alone Wyeth Lederle 's meningococcal C conjugate vaccine ( Meningitec™ ) , give concomitantly Tritanrix™-HepB/Hiberix™ use benchmark vaccine antigens except MenA . The immunogenicity MenA also evaluate .</brief_summary>
	<brief_title>Immunogenicity &amp; Safety Study Vaccine Against Meningitis Infants ( 2,4,6 Months ) After Hepatitis B Birth Dose .</brief_title>
	<detailed_description>Randomized study five group receive one follow vaccination regimen birth dose hepatitis B vaccine : One 3 lot GSK Biologicals ' Hib-MenAC mixed GSK Biologicals ' Tritanrix™-HBV ( 3 different group ) GSK Biologicals ' Tritanrix™-HBV/Hiberix™ GSK Biologicals ' Tritanrix™-HBV/Hiberix™ +Meningitec™</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion criterion : • Healthy infant 5683 day age , write informed consent obtain parent , born gestation period 36 42 week receive birth dose hepatitis B vaccine within first 72 hour life . Exclusion criterion : Any confirm suspected immunosuppressive immunodeficient condition , base medical history &amp; physical examination . Planned administration/administration vaccine foreseen study protocol within 30 day first dose study vaccine , plan administration study period exception oral polio vaccine ( OPV ) . Use investigational nonregistered drug vaccine study vaccine ( ) within 30 day precede first dose study vaccine , plan use study period . Chronic administration ( &gt; 14 day ) immunosuppressant immunemodifying drug since birth . Bacille CalmetteGuérin ( BCG ) vaccine receive first 2 week life . Previous vaccination diphtheria , tetanus , pertussis , Haemophilus influenzae type b , and/or meningococcal disease .</criteria>
	<gender>All</gender>
	<minimum_age>56 Days</minimum_age>
	<maximum_age>83 Days</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>